{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:02:45Z","timestamp":1783699365186,"version":"3.55.0"},"reference-count":10,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T00:00:00Z","timestamp":1596412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:p>We observed a severe case of cerebral toxoplasmosis in a 22\u2010year\u2010old woman diagnosed with dermatomyositis in 2016 in Venezuela, and treated with rituximab and azathioprine. The patient met clinical and microbiological criteria. Treatment with pyrimethamine and sulfadiazine was initiated, and the patient was discharged. She was rehospitalized with signs and symptoms of a manic episode. During hospitalization, the patient developed acute kidney injury related to sulfadiazine crystalluria. Finally, acute kidney injury was resolved and the patient was successfully discharged.<\/jats:p>","DOI":"10.1111\/bcp.14445","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T17:29:15Z","timestamp":1593278955000},"page":"1525-1528","source":"Crossref","is-referenced-by-count":7,"title":["Cerebral toxoplasmosis associated with treatment with rituximab, azathioprine and prednisone for dermatomyositis"],"prefix":"10.1111","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-2730","authenticated-orcid":false,"given":"Celia","family":"Casta\u00f1o\u2010Amores","sequence":"first","affiliation":[{"name":"Hospital pharmacy, Hospital San Cecilio  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pelayo","family":"Nieto\u2010G\u00f3mez","sequence":"additional","affiliation":[{"name":"Hospital pharmacy, Hospital San Cecilio  Granada Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,8,3]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.10.015"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.374"},{"key":"e_1_2_8_4_1","volume-title":"Product information for MabThera\u00ae","author":"European Medicines Agency (EMA)","year":"2020"},{"key":"e_1_2_8_5_1","volume-title":"Ficha t\u00e9cnica de Imurel\u00ae","author":"Agencia Espa\u00f1ola del Medicamento y Productos Sanitarios (AEMPS)","year":"2019"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_8_7_1","unstructured":"The use of the WHO\u2013UMC system for standardised case causality assessment. Accessed from:http:\/\/www.WHO-UMC.org\/graphics\/4409.pdf[last accessed on 2020Jun03]"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20849"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.6.763"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2017.3758"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.14445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bcp.14445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.14445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:54:18Z","timestamp":1693655658000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.14445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.1111\/bcp.14445"],"URL":"https:\/\/doi.org\/10.1111\/bcp.14445","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,3]]}}}